We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $34.9B
1-Year Est. Return 18.88%
This Fund
S&P 500
This Quarter Est. Return
+5.64%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+512.03%
AUM
$11.3B
AUM Growth
+$589M
Cap. Flow
+$20.5M
Cap. Flow %
0.18%
Top 10 Hldgs %
17.02%
Holding
1,387
New
148
Increased
486
Reduced
533
Closed
92

Top Buys

Rank Stock Value
1
FTV icon
Fortive
FTV
+$47.4M
2
AGN
Allergan plc
AGN
+$38.9M
3
NVRO
NEVRO CORP.
NVRO
+$24.1M
4
NFLX icon
Netflix
NFLX
+$21.5M
5
WM icon
Waste Management
WM
+$21.3M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$45.3M
2
MDVN
MEDIVATION, INC.
MDVN
+$33.2M
3
DHR icon
Danaher
DHR
+$28.3M
4
FLTX
Fleetmatics Group PLC
FLTX
+$25.2M
5
HCSG icon
Healthcare Services Group
HCSG
+$24.7M

Sector Composition

Rank Sector Weight
1 Healthcare 19.99%
2 Technology 15.43%
3 Financials 11.87%
4 Industrials 11.27%
5 Consumer Discretionary 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
T icon
151
AT&T
T
$159B
$19.4M 0.17%
632,849
-36,618
-5% -$1.16M
THS
152
DELISTED
Treehouse Foods
THS
$19.3M 0.17%
221,551
+13,342
+6% +$1.28M
CLX icon
153
Clorox
CLX
$11.6B
$19.3M 0.17%
154,041
+4,258
+3% +$558K
WMGI
154
DELISTED
Wright Medical Group Inc
WMGI
$19.2M 0.17%
784,129
+772,341
+6,552% +$17.8M
PRLB icon
155
Protolabs
PRLB
$1.79B
$19.1M 0.17%
318,218
-189,643
-37% -$10.9M
KMI icon
156
Kinder Morgan
KMI
$71.7B
$18.8M 0.17%
811,589
-274,071
-25% -$5.81M
CMCSA icon
157
Comcast
CMCSA
$85B
$18.7M 0.17%
563,052
+191,276
+51% +$6.37M
UAA icon
158
Under Armour
UAA
$2.84B
$18.3M 0.16%
472,223
-17,881
-4% -$722K
DVAX
159
DELISTED
Dynavax Technologies
DVAX
$18.2M 0.16%
1,738,506
+1,360,734
+360% +$19.6M
LLY icon
160
Eli Lilly
LLY
$1.02T
$18.2M 0.16%
226,579
+28,633
+14% +$2.29M
VWO icon
161
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$17.7M 0.16%
471,617
+68,406
+17% +$2.55M
BRK.A icon
162
Berkshire Hathaway Class A
BRK.A
$1.1T
$17.7M 0.16%
82
– –
G icon
163
Genpact
G
$5.96B
$17.7M 0.16%
738,132
-56,483
-7% -$1.4M
SHAK icon
164
Shake Shack
SHAK
$2.53B
$17.6M 0.16%
508,046
+18,113
+4% +$671K
PRGO icon
165
Perrigo
PRGO
$1.4B
$17.5M 0.15%
189,786
-18,772
-9% -$1.73M
NUVA
166
DELISTED
NuVasive, Inc.
NUVA
$17.4M 0.15%
260,272
+14,939
+6% +$952K
RMD icon
167
ResMed
RMD
$30.6B
$17.1M 0.15%
263,914
+5,749
+2% +$383K
SDY icon
168
State Street SPDR S&P Dividend ETF
SDY
$21.7B
$17M 0.15%
201,419
-3,715
-2% -$317K
VEA icon
169
Vanguard FTSE Developed Markets ETF
VEA
$229B
$16.8M 0.15%
450,017
+20,135
+5% +$740K
NORD
170
DELISTED
Nord Anglia Education, Inc.
NORD
$16.6M 0.15%
762,716
+3,029
+0.4% +$66.3K
CTAS icon
171
Cintas
CTAS
$81.9B
$16.3M 0.14%
577,508
-17,932
-3% -$491K
ZBRA icon
172
Zebra Technologies
ZBRA
$14B
$16M 0.14%
229,710
-5,860
-2% -$360K
IVZ icon
173
Invesco
IVZ
$13.1B
$16M 0.14%
510,418
-26,822
-5% -$788K
EVH icon
174
Evolent Health
EVH
$348M
$15.9M 0.14%
644,162
+302,592
+89% +$7.07M
BABA icon
175
Alibaba
BABA
$293B
$15.4M 0.14%
145,501
+11,000
+8% +$1.02M
5 6
7
8 9

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return

William Blair & Company's Q3 2016 Portfolio in Review

As of Q3 2016, William Blair & Company held 1,387 positions worth $11.3B, up 5.5% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

William Blair & Company's Q3 2016 filing shows 148 new, 486 increased, 533 reduced and 92 closed positions. Its largest new stake was Fortive: 1,476,720 shares worth $47.4M. The largest sale was Gilead Sciences, an estimated $45.3M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.

  • William Blair & Company's largest Q3 2016 buy was Fortive: 1,476,720 shares worth $47.4M.
  • William Blair & Company added most to Allergan plc in Q3 2016, an estimated $38.9M increase.
  • William Blair & Company's biggest Q3 2016 reduction was Gilead Sciences, cutting an estimated $45.3M.
  • William Blair & Company fully exited IHS INC CL-A COM STK in Q3 2016, selling an estimated $6.24M.
  • William Blair & Company's ten largest holdings make up 17% of its $11.3B portfolio in Q3 2016.
  • William Blair & Company opened 148 new positions and closed 92 in Q3 2016.
  • William Blair & Company's portfolio value rose 5.5% quarter-over-quarter to $11.3B.

Based on William Blair & Company's 13F filing for Q3 2016, filed 14 Nov 2016.